Bausch + Lomb to Participate in Citi Global Healthcare Conference
VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and Executive Vice President and Chief Financial Officer Sam Eldessouky will participate in a fireside chat at the 2025 Citi Global Healthcare Conference on Wednesday, Dec. 3, 2025, at 9:00 a.m. ET.
A live webcast, as well as a post-event recording, will be available on the Investor Relations page of the Bausch + Lomb website: http://ir.bausch.com/investors/events-presentations.
About Bausch + Lomb
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.
© 2025 Bausch + Lomb.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251118094841/en/
Media Contact:
Chris Clark
[email protected]
(848) 360-1100
Investor Contact:
George Gadkowski
[email protected]
(877) 354-3705 (toll free)
Source: Bausch + Lomb Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
- Apple to increase spend with Broadcom to produce billions more U.S. chips
- KONAMI GROUP’s Konami Gaming, Inc. First to Submit Manufacturer License Application in Japan’s Emerging IR Market
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share